Using primary amines to create new drugs and drug delivery systems
Primary Amines as Versatile Precursors for the Synthesis of Bioactive Molecules and Macromolecular Drug Carriers
['FUNDING_OTHER'] · TEXAS A&M UNIVERSITY · NIH-10906747
This study is exploring new ways to create medicines that can help treat diseases by using special building blocks to design tiny molecules that target specific proteins in the body, making treatments more effective and tailored for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS A&M UNIVERSITY (nih funded) |
| Locations | 1 site (COLLEGE STATION, UNITED STATES) |
| Trial ID | NIH-10906747 on ClinicalTrials.gov |
What this research studies
This research focuses on developing new therapeutic agents by utilizing primary amines as building blocks for synthesizing bioactive molecules. It involves creating small-molecule inhibitors or agonists that can effectively bind to disease-related proteins, triggering beneficial molecular responses. The project also aims to innovate methods for modifying complex natural products and designing polymeric drug delivery systems that can release medications in response to specific stimuli. This multidisciplinary approach combines chemistry with drug development to enhance treatment options for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that could benefit from new therapeutic agents targeting specific proteins.
Not a fit: Patients with well-established treatments that do not require new drug development may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and safer drugs for various diseases.
How similar studies have performed: Other research has shown success in using similar chemical approaches to develop new therapeutics, indicating a promising avenue for innovation.
Where this research is happening
COLLEGE STATION, UNITED STATES
- TEXAS A&M UNIVERSITY — COLLEGE STATION, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MICHAUDEL, QUENTIN NICOLAS — TEXAS A&M UNIVERSITY
- Study coordinator: MICHAUDEL, QUENTIN NICOLAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.